期刊
CURRENT PHARMACEUTICAL DESIGN
卷 27, 期 29, 页码 3173-3179出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612827666210125154749
关键词
Blood pressure; hypertension; gender; disparities; prevalence; awareness; treatment; control
资金
- Romanian Society of Hypertension
Gender differences play a significant role in hypertension epidemiology, with clear disparities in prevalence, awareness, treatment, and control between different age groups of men and women, mainly influenced by hormonal status. In high cardiovascular risk European countries like Romania, gender gaps in hypertension prevalence may decrease over time, with females expected to maintain higher awareness and treatment rates than males, while an upward trend in blood pressure control is predicted only for women.
The gender effects in arterial hypertension (HT) epidemiology remain poorly clarified to date. We present an up-to-date review of the data regarding gender disparities in HT's prevalence, awareness, treatment, and control. Based on the data from three consecutive national-representative SEPHAR (Study for the Evaluation of Prevalence of Hypertension and Cardiovascular Risk in Romania) surveys conducted between 2005 and 2016, we provide insights into gender differences in HT's epidemiology and their 11-years the evolutionary trend in a high-CV risk European country. Our data displays gender effects in different age-dependent epidemiological patterns in terms of hypertension prevalence, awareness, treatment, and control, mainly due to hormonal status. Hypertension's prevalence is higher in younger men and older women. Although women are more often aware of their hypertensive condition and receive more often antihypertensive treatment, BP control is lower in older women compared to men of the same age, mainly due to a higher treatment side-effect rate. There is no solid evidence that different antihypertensive drugs exhibit different effects in lowering BP values between genders. In high CV risk European countries like Romania, if all the influencing conditions remain similar to those in the past 11 years, gender discrepancies in terms of HT's prevalence will diminish over time, awareness and treatment of hypertension will continue to be higher in females than in men, with an upward trend of BP control predicted only for women, while in men HT treatment control rate is expected to stagnate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据